Oral Antidiabetic Drugs Market by Drugs Class Category (Sulfonylureas, Meglitinides, Biguanides and Alpha-glucosidase inhibitors) for Type 2 Diabetes mellitus - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Global oral antidiabetic drug market is expected to reach USD 35.91 billion by 2022, growing at a CAGR of 10.2% between 2017 and 2022.

06-Jan-2017 | Number of pages: 110 | Report Code: ZMR-687 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the oral antidiabetic drugs market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD billion). The study includes drivers and restraints of the oral antidiabetic drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the oral antidiabetic drugs market on a global level.

In order to give the users a comprehensive view of the Oral antidiabetic drugs market, we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the oral antidiabetic drugs market has also been included. The study encompasses a market attractiveness analysis, wherein the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the oral antidiabetic drugs market by segmenting the market based on drugs class and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. The drugs class segmentation includes sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. The meglitinides class is further segmented into repaglinide and nateglinide. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further sub-segmented into U.S., Canada, China, Japan, and Brazil.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global oral antidiabetic drugs market include Eli Lilly, Abbott, Biocon, Sanofi, Sunpharma, Novartis, Novo Nordisk, Merck and Pfizer.

This report segments the global oral antidiabetic drugs Market as follows:

Global Oral Antidiabetic Drugs Market: Drugs Class Analysis

  • Sulfonylureas
    • Glimepiride
    •  Gliclazide
    •  Glyburide
    •  Others
  • Meglitinides
  • Repaglinide
  • Nateglinide
  • Biguanides
    • Metformin
    •  Others
  • Alpha-glucosidase inhibitors
    • Acarbose
    •  Voglibose
    •  Others
  • Others

Global Oral Antidiabetic Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Thrombus Precursor Protein Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1918 | Report Format:

Global Thrombus Precursor Protein Market: Overview One of the components of the fibrinolytic and coagulation pathways is the thrombus precursor protein (TpP). The thrombus precursor protein acts as a biomarker that specifies the exposure of the people to serious cardiovascular diseases, especial...Read More

Oncology Adjuvants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1914 | Report Format:

Global Oncology Adjuvants Market: Overview Oncology adjuvant treatment is a treatment for the cancer therapy, wherein which after the primary treatment the cancer treatment is involved. The reoccurrence of the cancer is minimized by the oncology adjuvants treatment. The oncology adjuvant therapy...Read More

Limb Salvage Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1911 | Report Format:

Global Limb Salvage Systems Market: Overview The alternative name for the limb salvage is limb sparing surgery. In the case of the bone tumors, this is the surgical procedure that is mostly preferred so that there are no chances of amputations. In the limb salvage surgery, the functional limb im...Read More

Meningococcal Disease Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1899 | Report Format:

Global Meningococcal Disease Treatment Market: Overview Meningococcal disease is a rigorous infection of meninges; in this disease, the membrane of the brain is affected which causes the brain damage. It is caused by Neisseria meningitides bacteria. This bacterium also causes bloodstream infecti...Read More

Injectable Anti-Wrinkle Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1897 | Report Format:

Global Injectable Anti-Wrinkle Market: Overview In order to reduce the wrinkles and the skin lines, people undergo treatment which is known as injectable antiwrinkle treatment where the drugs are injected into the treatment area. It can also make the skin tight and can fill the sagging skin, fro...Read More

Choose License Type:
Latest Published Reports

View All Published Reports